Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
Pharming Group NV (PHGUF) had Debt to Equity Ratio of 0.42 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$376.13M |
|
$2.85M |
|
$45.50M |
|
$330.63M |
|
$350.29M |
|
$25.84M |
|
$-13.00M |
|
$12.85M |
|
$12.85M |
|
$2.54M |
|
$2.54M |
|
$2.54M |
|
$2.54M |
|
$25.84M |
|
$37.06M |
|
688.77M |
|
746.87M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$299.47M |
|
$7.23M |
|
$200.49M |
|
$499.96M |
|
$115.79M |
|
$107.07M |
|
$107.07M |
|
$222.86M |
|
$277.10M |
|
$141.56M |
|
$277.10M |
|
701.68M |
|
| Cash Flow Statement Financials | |
$54.71M |
|
$26.25M |
|
$1.50M |
|
$54.94M |
|
$145.31M |
|
$90.36M |
|
$13.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.59 |
|
-- |
|
-- |
|
0.28 |
|
|
Debt to Equity Ratio |
0.42 |
87.90% |
|
6.87% |
|
6.87% |
|
9.85% |
|
3.42% |
|
0.76% |
|
$53.96M |
|
-- |
|
-- |
|
-- |
|
0.75 |
|
0.70 |
|
6.88 |
|
53.08 |
|
0.92% |
|
1.79% |
|
0.51% |
|
0.66% |
|
$0.39 |
|
$0.07 |
|
$0.07 |
|